Inipharm

Inipharm is a biopharmaceutical company that researches and develops novel therapies for the treatment of severe liver diseases.

Funding reportedLast round: Series A

BiotechnologySeattle, United States

Follow Inipharm and see its new rounds in your feed.Start following

What company datasets say Inipharm raised

Funding, as reported

Reported in all$35Min dollars

Rounds1

Last roundSeries A

Last round size$35M

Last round dateNov 2020

From Inipharm's own website: 1 on the team.

Investors who name them

Each firm lists Inipharm on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

What they build

Built with from their website

PWAViewport MetaFirebaseMicrosoft ExchangeMicrosoft 365 Apps & ServicesMobile FriendlyOpen GraphHTTP/3GoDaddy DomainsMicrosoft Exchange Online

+7 more

HSTSMicrosoft 365OutlookMicrosoft Email ProvidersGoDaddy HostingGoogle Search ConsoleGoogle Firebase Hosting

Startups like it

Add your raise, your deck and your story, and put Inipharm in front of investors. Or tell us what we have wrong.